Topic: Volcano Corporation

Volcano Corporation (VOLC) reported EPS of 9 cents in the fourth quarter; well above the Zacks Consensus Estimate for a loss of 3 cents, and the year-ago result of 4 cents. Moreover, strong capital equipment sales in the US, and a favorable ...
The health care equipment sub-industry for the next 12 months is neutral, according to S&P reports. Meridian Bioscience, Inc. (VIVO) operates as an integrated life science company, engaging in the development, manufacture, sale, and distribution of diagnostic test kits primarily for respiratory, ...
Volcano Corporation (VOLC) Q2 2009 Earnings Call Transcript August 04, 2009 5:00 pm ET. These include statements related to the guidance about financial and operational results; growth strategies; product development and clinical trial programs, and anticipated results of related studies; market acceptance ...
Volcano Corp. (VOLC) Q4 2008 Earnings Call February 17, 2009 5:00 am ET. Keep in mind that in the fourth quarter of 2007, we recorded $1.1 million of revolution catheter revenue related to stocking orders in Japan. As we have indicated previously, ...
Volcano Corporation (VOLC) Q3 2008 Earnings Call Transcript November 05, 2008 5:00 pm ET. With me today is Scott Huennekens, Volcano's President and Chief Executive Officer. IVUS system sales increased 78% and IVUS disposable revenues increased 29% versus the third quarter of ...
Volcano Corporation (VOLC) Q2 2008 Earnings Call Transcript August 05, 2008 5:00 pm ET. As we discussed in our last call, while our order activity from the US, European and OEM customers has continued to experience steady growth, many of our customers' ...